PLASMA LABS ADVANCE BONE HEALTH PROFILE
Original price was: ₹6,500.00.₹2,799.00Current price is: ₹2,799.00.
-
Tests Covered:
-
Vitamin D Total (25 Hydroxy)
-
ANA (Antinuclear Antibody)
-
Anti-CCP (Cyclic Citrullinated Peptide)
-
ASO (Anti-Streptolysin O) – Quantitative
-
C-Reactive Protein (CRP)
-
Calcium (Total)
-
CBC (Complete Blood Count)
-
ESR (Erythrocyte Sedimentation Rate)
-
Glucose (Fasting Blood Sugar)
-
Total Protein
-
Rheumatoid Arthritis Factor (RA)
-
Urine Routine Examination
-
Uric Acid
-
Description
Ensure strong and healthy bones with the Advance Bone Health Profile, a detailed diagnostic package that covers essential markers for bone, joint, and overall health.
Tests Covered:
-
Vitamin D Total (25 Hydroxy): Assesses vitamin D levels vital for bone strength
-
ANA (Antinuclear Antibody): Screens for autoimmune disorders affecting joints and tissues
-
Anti-CCP (Cyclic Citrullinated Peptide): Detects early signs of rheumatoid arthritis
-
ASO (Anti-Streptolysin O) – Quantitative: Evaluates past streptococcal infections linked to joint issues
-
C-Reactive Protein (CRP): Identifies inflammation in the body
-
Calcium (Total): Measures calcium levels essential for bone health
-
CBC (Complete Blood Count): Analyzes blood health to detect anemia or infection
-
ESR (Erythrocyte Sedimentation Rate): Monitors inflammation levels
-
Glucose (Fasting Blood Sugar): Checks blood sugar for overall health insight
-
Total Protein: Evaluates protein status, key for bone and tissue health
-
Rheumatoid Arthritis Factor (RA): Detects rheumatoid arthritis and joint inflammation
-
Urine Routine Examination: Assesses general health and urinary tract conditions
-
Uric Acid: Evaluates risk of gout and other joint-related concerns
✅ NABL Accredited Reports for accuracy and reliability.
✅ Free Home Sample Collection – convenience at your doorstep.
✅ Fast Reports on WhatsApp – quick and hassle-free.
✅ Pay Later Option – 50% now, rest in easy 0% EMI.
✅ Comprehensive diagnostic solutions with expert guidance.
Reviews
There are no reviews yet.